1
|
Porto JG, Raymo A, Suarez Arbelaez MC, Gurayah AA, Ramasamy R. Patient Satisfaction and Long-Term Clinical Outcomes in Adolescent Sub-inguinal Microscopic Varicocelectomy. Cureus 2023; 15:e44349. [PMID: 37654902 PMCID: PMC10465803 DOI: 10.7759/cureus.44349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/29/2023] [Indexed: 09/02/2023] Open
Abstract
INTRODUCTION AND OBJECTIVE The long-term outcomes of varicocelectomy in adolescents is debated. The aim of this study was to evaluate symptom improvement, hypogonadism, and paternity in those who underwent adolescent sub-inguinal microscopic varicocelectomy. MATERIAL AND METHODS A retrospective chart review was done of adolescents (median=19, interquartile range (IQR)=16-19.75 years) who underwent microscopic varicocelectomy between 2011 and 2021. Demographics, surgical indications, and outcomes were collected, as well as pre- and postoperative hormone levels and semen parameters. A questionnaire was prospectively collected to evaluate orchialgia, paternity, and symptoms of hypogonadism. Descriptive statistics and t-tests were performed, with significance assessed at p-value < 0.05. RESULTS A total of 46 adolescents were included. Age at the time of diagnosis and surgery was 19 (IQR=16-20) and 19 (IQR= 18-21) years, respectively. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), and total testosterone were not affected after surgery. Similarly, semen parameters were preserved after varicocelectomy, with median concentration increasing from 12x106/ml to 16x106/ml but not reaching significance (p=0.272). A total of 26 men completed the questionnaire. The age of responders was 22 (IQR=21-24) years, and the time after having had the varicocelectomy was 36.5 (IQR= 18.25-62.25) months. Orchialgia persisted in five men, and three reported having a recurrence. Two men, who had a preoperative abnormal semen analysis, were actively trying to have children and reported successfully having achieved natural pregnancies. None of the patients reported having hypogonadism, and none were receiving testosterone therapy. CONCLUSION Our study suggests that microscopic varicocelectomy in adolescents appears to be a safe and feasible procedure with a low rate of syndrome recurrence and no association with symptoms or biochemical evidence of hypogonadism.
Collapse
Affiliation(s)
- Joao G Porto
- Desai Sethi Urology Institute, University of Miami, Miami, USA
| | - Adele Raymo
- Department of Pediatric Urology, Nicklaus Children's Hospital, Miami, USA
| | | | - Aaron A Gurayah
- Desai Sethi Urology Institute, University of Miami, Miami, USA
| | | |
Collapse
|
2
|
Verhovsky G, Giladi M, Tzur D, Afek A, Keinan-Boker L, Derazne E, Kaminsky D, Hoffman A, Erlich T, Neuman T. Varicocele in adolescence and testicular cancer in young adulthood. Andrology 2022; 10:1575-1580. [PMID: 36068656 DOI: 10.1111/andr.13280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 06/19/2022] [Accepted: 08/22/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND Elevated intrascrotal temperature has been suggested as a risk factor for testicular cancer, which is the most common neoplasm among young men. Varicocele was linked to increased intrascrotal temperature, but whether it is associated with testicular cancer is unclear. OBJECTIVE To explore the possible association between varicocele at adolescence and the incidence of testicular cancer at adulthood. DESIGN, SETTING AND PARTICIPANTS This nationwide, population-based, historical cohort study includes 1,521,661 Israeli male adolecents (mean age 17.5 ± 0.4 years), who were screened for varicocele during the years 1967-2012, as part of their medical assessment prior to compulsory military service. The mean follow-up was 18± 4.2 years. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS The diagnosis of testicular cancer was ascertained from linkage of records to the the Israeli National Cancer Registry. Survival analysis was applied. RESULTS In total, 53,210 adolescents were diagnosed with varicocele stage 2 and 3 prior to military service. Of 1,988 (0.13% of the total cohort) men who were diagnosed with testicular cancer during follow up, 54 (0.1%) had varicocele prior to military service while 1934(99.9%) did not, p = 0.213. The age at cancer diagnosis and the distribution of seminomas vs. non-seminomas did not differ significantly between those with and without varicocele in adolescence. In a multivariable analysis controlling for sociodemographic factors, varicocele was not associated with testicular cancer, odds ratio = 0.816 (CI 0.615-1.083). CONCLUSIONS Varicocele in adolecents was not found to be associated with testicular cancer in young adults. PATIENT SUMMARY In light of the theoretical association between varicocele and testicular cancer, we conducted this large population study. We found no association between varicocele in young adoulthoot and testicular cancer later in life. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Guy Verhovsky
- Department of Urology, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.,Israel Defense Forces Medical Corps, Ramat Gan, Israel.,Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.,Thesis, as a part of MPH requirements in Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 699780, Israel
| | - Moshe Giladi
- Israel Defense Forces Medical Corps, Ramat Gan, Israel.,Department of Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Military Medicine, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, 9112102, Israel.,Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 699780, Israel.,Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - Dorit Tzur
- Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 699780, Israel
| | - Arnon Afek
- Central Management, Chaim Sheba Medical Center, Tel Hashomer, Israel.,Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - Lital Keinan-Boker
- Israel Center for Disease Control, Ministry of Health, Tel Hashomer, Israel.,School of Public Health, University of Haifa, Haifa, Israel
| | - Estela Derazne
- Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
| | - Dan Kaminsky
- Israel Defense Forces Medical Corps, Ramat Gan, Israel
| | - Azik Hoffman
- Department of Urology, Rambam Medical Center, Heifa, Israel
| | - Tomer Erlich
- Israel Defense Forces Medical Corps, Ramat Gan, Israel.,Department of Urology, Sheba Medical Center, Ramat Gan, Israel.,Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.,Department of Military Medicine, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, 9112102, Israel
| | - Tzahi Neuman
- Department of Pathology, Hadassah Hebrew University Hospital, Jerusalem, Israel
| |
Collapse
|